ARCHIVES

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

This article is from The Cancer Letter archive.

Vol. 30 No. 17 | April 23, 2004

Download PDF Visit The Full Archive

Related Articles

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

UPCI Recruits Shin To Lead Head & Neck Cancer Program.

April 27, 2001

NCI Progress: Biomarker Labratories Funded To Develop Early Detection Methods

October 22, 1999

NCCS Networker Volume 4 Issue 3, Summer 1990

June 13, 1990

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007